Lv11
10 积分 2024-01-26 加入
Targeting CDKs in the RNAPII Transcription Cycle
9小时前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
9小时前
已完结
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
3天前
已完结
Development of XYD113 as a potent and highly selective GSPT1 degrader for cancer therapy
1个月前
已完结
Molecular glue degraders versus PROTACs: a novel paradigm in targeted protein degradation
1个月前
已完结
Abstract NG10: First-in-class dual AR/AR-V7 molecular glue degraders targeting the undruggable N-terminal domain to overcome therapeutic resistance in prostate cancer
1个月前
已关闭
CC-90009, a Novel Cereblon E3 Ligase Modulator, Targets GSPT1 for Degradation to Induce Potent Tumoricidal Activity Against Acute Myeloid Leukemia (AML)
1个月前
已完结
Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide
1个月前
已完结
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
2个月前
已完结
Induction of Apoptosis and Activation of Endoplasmic Reticulum Stress by SJ6986 in Diffuse Large B-cell Lymphoma
2个月前
已完结
皖公网安备34019202002308
